Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Lidocaine and Triamcinolone vs Saline Trigger Point Injection for Treatment of Chronic Abdominal Wall Pain

NCT02748395 is registered in ClinicalTrials.gov with Temple University as lead sponsor.

NCT NCT02748395
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02748395 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Lidocaine and Triamcinolone vs Saline Trigger Point Injection for Treatment of Chronic Abdominal Wall Pain
Lead sponsor
Temple University
Phase
Phase 4
Overall status
Withdrawn
Start date
May 31, 2016
Completion date
Not reported
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

abdominal cutaneous nerve entrapment syndrome, chronic abdominal wall pain